Omada just performed one of the largest GLP-1 patient surveys of its kind. Stigma remains a barrier to treatment, patients want more time with providers, and dynamics around initiating GLP-1 conversations are shifting. Read our survey findings. https://t.co/n4zD6mGHTc
Our new 12-week study looked at how body composition changes when people lose weight on GLP-1s. We analyzed who lost body fat while preserving muscle mass, and how they felt and functioned––with Omada’s support versus without it. Read the whitepaper now. https://t.co/wFCMWibfXR
Congratulations to @omadahealth on one year as a #NasdaqListed company! Relive this unforgettable bell-ringing moment of Co-Founder & CEO @seanduffy with his five-year-old daughter, Aletta. Here's to many more milestones ahead.
One year post-IPO: greater scale, accelerated financial performance and 2M+ members served. What hasn’t changed is our focus on better outcomes, lower costs, and earned trust. We’re here to bend the curve of chronic disease, one day at a time. #CelebrateOMDA
3,000+ GLP-1 patients just told us what’s working, what’s breaking, and what they wish their employers understood. Read the results of our 2026 GLP-1 patient survey: https://t.co/n4zD6mGHTc
In our latest 12-week study on body composition and GLP-1s, the group who received Omada’s support reported greater improvements in lifestyle change, physical function, and confidence in their ability to lose weight. Read the full white paper now. https://t.co/wFCMWibfXR
Members don’t feel accountable to a prescription or an app; they feel accountable to people. Omada’s GLP‑1 care model is—and will remain—human‑led, with AI used to scale that connection, not replace it.
Learn more: https://t.co/tZymW2g6Ke
High cholesterol rarely shows up alone—it appears alongside obesity, hypertension, & diabetes, quietly stacking cardiovascular risk. Omada for Cholesterol treats it as part of a full system, with between‑visit support that ties labs to daily behavior.
https://t.co/LtSLpPm3UP
The GLP‑1 market is complex: multiple indications, fragmented access, shifting benefit designs. Employers need help with navigating the complicated space.
Omada offers GLP‑1 companion care, prescribing, and flexible options for employers. Learn more: https://t.co/tZymW2g6Ke
It’s about more than weight loss – when taking GLP-1s. Members should consider how changes in muscle mass affect their long‑term health. Our latest whitepaper unpacks it. https://t.co/EyMkyE2jQ8
See how Omada’s care team helps people take real‑life obstacles and turn them into small steps forward.
Our care teams are supported by AI to help deliver tangible outcomes across key help metrics. Learn more: https://t.co/sqTuv2Op9z
The market is moving faster than real world results, Omada is focused on evidence. OmadaSpark, built with @AWSAI & @AIatMeta, gives safe, context-aware nutrition guidance in real time. https://t.co/asHSMaQpaS
Most employers think managing GLP-1 coverage and cost is important, but finding a financially sustainable path can be difficult. Not anymore. Introducing Omada’s GLP-1 Flex Care, a solution that empowers employers with a benefits strategy for every budget:https://t.co/6xdqiYEz8j
$OMDA Q1 2026:
📈 Revenue +42% YoY to $78M
👥 1M+ Total Members (+51% YoY)
📉 GAAP net loss narrowed to $3M; positive Adjusted EBITDA (non-GAAP) in our highest-cost quarter
Reach, enrollment, engagement, efficiency each delivered for a milestone quarter. https://t.co/ifsFHpdY88
Most employers think managing GLP-1 coverage and cost is important, but finding a financially sustainable path can be difficult. Introducing Omada’s GLP-1 Flex Care, a solution that empowers employers with a benefits strategy for every budget. https://t.co/6xdqiYEz8j
For employers, the real GLP‑1 question isn’t just “What do they cost?”—it’s “What do we get for what we spend?” Omada acts as a GLP‑1 value maximizer, wrapping coaching and behavior change around meds to improve persistence and long‑term outcomes. https://t.co/RO7e4fhT1D
Benefits leaders know that a flexible strategy for GLP-1s isn’t a nice-to-have; it’s a must in this rapidly expanding and costly landscape. Omada’s GLP-1 Flex Care helps employers widen access and improve long-term outcomes. Coming in 2026. Learn more: https://t.co/6xdqiYEz8j
What is the best GLP-1 benefits strategy? A flexible one. Omada’s GLP-1 Flex Care gives employers more options when it comes to increasing access to these medications, without sacrificing outcomes. https://t.co/0cUsFXFYkI
We are now available through @OptumRx's Weight Engage, making Omada available for employers to purchase through all 3 largest PBMs,
OptumRx clients can now offer members our GLP-1 medication care paired with behavior change.
Learn more: https://t.co/dFwjoSDtcU
If your GLP‑1 strategy stops at “pounds lost,” you’re missing value. Omada helps members lose more of the right weight, and improve body composition and function. https://t.co/bvG1jHplwO